journal article·2025-09-17

Nebulized Lipid Nanoparticles Deliver mRNA to the Liver for Treatment of Metabolic Diseases

Hongyu Ren, Xiaolu Yu, Mengyao Li, Zijin Luo, Yi Lin, Yanan Meng, Qiang Cheng, Tuo Wei

Nano Letters· Volume 25· Issue 37
Publisher page

Abstract

An optimal administration approach is critical for effective mRNA delivery and treatment. Nebulizer inhalation offers a mild, convenient, and noninvasive strategy with high translational potential but primarily focused on lung delivery. In this study, we found that surface charges influence tissue targeting of mRNA lipid nanoparticle (mRNA-LNP) postnebulization. Charged mRNA-LNPs showed lung tropism, while neutral ones targeted the liver when administered via a microsprayer aerosolizer. Using nebulized liver-targeted LNPs (NebuLi LNPs), we successfully delivered therapeutic mRNAs for the treatment of metabolic diseases. In a Hereditary Tyrosinemia Type 1 model, fumarylacetoacetate hydrolase mRNA was effectively delivered to the liver, which helped to maintain mouse body weight, preserve liver function, and delay liver fibrosis. In a Type 2 diabetes model, dulaglutide mRNA was effectively expressed in the liver and exhibited good hypoglycemic effects. Overall, the NebuLi LNPs delivery platform offers a promising noninvasive strategy for metabolic disease treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Liver Disease Diagnosis and Treatment · Endoplasmic Reticulum Stress and Disease · Lipid Membrane Structure and Behavior

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology

Chinese Academy of Sciences

Beijing Institute for Stem Cell and Regenerative Medicine

University of Chinese Academy of Sciences

Department of Biomedical Engineering, College of Future Technology, Beijing Advanced Center of RNA Biology (BEACON)

Peking University

Beijing Life Science Academy, Yingcai South First Street, Changping District, Beijing 102200, China

Funding

National Key Research and Development Program of China · Natural Science Foundation of Beijing Municipality · fund from the Key Laboratory of Organ Regeneration and Reconstruction, Chinese Academy of Sciences · Project from Beijing Institute for Stem Cell and Regenerative Medicine · the Open Research Fund of Beijing Advanced Center of RNA Biology (BEACON) at Peking University · the Beijing Life Science Academy · the "Open Competition to Select the Best Candidates" Key Technology Program for Cell and Gene Therapy of NCTIB

References (26)

Show source-provided references
1. 10.1038/s41573-024-00977-610.1038/s41573-024-00977-6 ↗
2. 10.1038/s41392-022-01007-w10.1038/s41392-022-01007-w ↗
3. 10.1002/EXP.2021008210.1002/EXP.20210082 ↗
4. 10.1038/s41467-023-42189-310.1038/s41467-023-42189-3 ↗
5. 10.1038/s41467-021-26714-w10.1038/s41467-021-26714-w ↗
6. 10.1002/adma.20230922510.1002/adma.202309225 ↗
7. 10.1038/s41565-023-01453-910.1038/s41565-023-01453-9 ↗
8. 10.1038/s41467-023-39768-910.1038/s41467-023-39768-9 ↗
9. 10.1038/s41565-023-01548-310.1038/s41565-023-01548-3 ↗
10. 10.1038/s41551-021-00786-x10.1038/s41551-021-00786-x ↗
11. 10.1073/pnas.230496612010.1073/pnas.2304966120 ↗
12. 10.1126/sciadv.ado479110.1126/sciadv.ado4791 ↗
13. 10.1038/s41565-020-0669-610.1038/s41565-020-0669-6 ↗
14. 10.1016/j.ymthe.2018.03.01010.1016/j.ymthe.2018.03.010 ↗
15. 10.1073/pnas.091060310610.1073/pnas.0910603106 ↗
16. 10.1002/anie.20120326310.1002/anie.201203263 ↗
17. 10.1038/gim.2017.10110.1038/gim.2017.101 ↗
18. 10.2147/TACG.S11331010.2147/TACG.S113310 ↗
19. 10.1016/j.stem.2021.04.01010.1016/j.stem.2021.04.010 ↗
20. 10.1016/S2213-8587(21)00113-310.1016/S2213-8587(21)00113-3 ↗
21. 10.1038/s41591-021-01394-710.1038/s41591-021-01394-7 ↗
22. 10.1038/nrendo.2012.14010.1038/nrendo.2012.140 ↗
23. 10.1016/j.addr.2018.07.00910.1016/j.addr.2018.07.009 ↗
24. 10.1080/00325481.2016.121826010.1080/00325481.2016.1218260 ↗
25. 10.1002/adma.20240981210.1002/adma.202409812 ↗
26. 10.1038/s41551-022-00847-910.1038/s41551-022-00847-9 ↗